An OS to Evaluate Effectiveness and Safety of Fixed-dose Combinations of FMS/AML or FMS/AML/HCTZ

Clinical trial NCT05413057 · RECRUITING

Trial details

NCT number: NCT05413057
Sponsor: Boryung Pharmaceutical Co., Ltd
Status: RECRUITING
Study type: OBSERVATIONAL

Hypertension,Essential

Start date: 2022-06-23
Primary completion: 2026-06-01
Enrollment: 20000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.